Related Experiment Videos

In vitro processing of human tumor necrosis factor-alpha

S Robache-Gallea1, V Morand, J M Bruneau

  • 1Domaine Thérapeutique Immunologie, Roussel Uclaf, Romainville, France.

Insights

Researchers identified a specific enzyme, proteinase-3 (PR-3), involved in processing tumor necrosis factor-alpha (TNF-alpha). This finding sheds light on the biological mechanisms regulating this important inflammatory cytokine.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • Tumor necrosis factor-alpha (TNF-alpha) is a key inflammatory cytokine.
  • TNF-alpha is initially synthesized as a 26-kDa membrane-bound precursor.
  • This precursor is cleaved to release a soluble 17-kDa active form.

Purpose of the Study:

  • To identify the specific enzyme responsible for processing the TNF-alpha precursor.
  • To investigate the role of serine proteinases in TNF-alpha maturation.

Main Methods:

  • In vitro translation of radiolabeled TNF-alpha precursor.
  • Analysis of processing activity in monocytic cell membrane preparations.
  • Use of purified proteinase-3 (PR-3) and inhibitors.
  • NH2-terminal sequencing of reaction products.

Main Results:

  • A serine proteinase activity in monocytic cells processed TNF-alpha precursor to the 17-kDa form.
  • Purified proteinase-3 (PR-3) exhibited similar processing activity.
  • A specific serine proteinase inhibitor did not block processing, but anti-PR-3 antibodies did.
  • Cleavage occurred between Val77 and Arg78, consistent for both membrane preparations and PR-3.

Conclusions:

  • Proteinase-3 (PR-3) is a likely candidate enzyme for processing TNF-alpha.
  • PR-3 may function as an accessory enzyme in TNF-alpha maturation.
  • These findings contribute to understanding TNF-alpha regulation.

Related Concept Videos